Trademark: 97091070
Word
PREDICTSCRIPT
Status
Pending
Status Code
730
Status Date
Friday, May 10, 2024
Serial Number
97091070
Mark Type
4
Filing Date
Monday, October 25, 2021
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Phenomics Health Inc. - Owner At Publication

Classifications
42 Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing
PREDICT SCRIPT

Trademark Events
Jul 5, 2022
Notification Of Non-Final Action E-Mailed
Oct 28, 2021
New Application Entered
Nov 8, 2021
New Application Office Supplied Data Entered
Jun 15, 2022
Assigned To Examiner
Jul 5, 2022
Non-Final Action Written
Jul 5, 2022
Non-Final Action E-Mailed
Jan 4, 2023
Teas Response To Office Action Received
Jan 4, 2023
Correspondence Received In Law Office
Jan 4, 2023
Teas/Email Correspondence Entered
Feb 10, 2023
Final Refusal Written
Feb 10, 2023
Final Refusal E-Mailed
Feb 10, 2023
Notification Of Final Refusal Emailed
Apr 27, 2023
Application Extension To Response Period - Received
Apr 27, 2023
Application Extension Granted/Receipt Provided
Aug 3, 2023
Teas Request For Reconsideration Received
Aug 3, 2023
Correspondence Received In Law Office
Aug 3, 2023
Teas/Email Correspondence Entered
Aug 8, 2023
Exparte Appeal Received At Ttab
Aug 8, 2023
Jurisdiction Restored To Examining Attorney
Aug 8, 2023
Ex Parte Appeal-Instituted
Aug 15, 2023
Approved For Pub - Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2023
Exparte Appeal Dismissed As Moot
Oct 19, 2023
Exparte Appeal Terminated
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Published For Opposition
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 20, 2023
Exparte Appeal Terminated
May 10, 2024
Sou Teas Extension Received
May 10, 2024
Sou Extension 1 Filed
May 10, 2024
Sou Extension 1 Granted
May 11, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24